<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A high-throughput screen of the cytotoxic activity of 2000 molecules from a commercial library in three human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines and two <z:mpath ids='MPATH_458'>normal</z:mpath> cell types identified the <z:chebi fb="0" ids="36420">acridine</z:chebi> acriflavin to be a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) active drug </plain></SENT>
<SENT sid="1" pm="."><plain>Acriflavine was active in cell spheroids, indicating good drug penetration and activity against hypoxic cells </plain></SENT>
<SENT sid="2" pm="."><plain>In a validation step based on primary cultures of patient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, acriflavine was found to be more active against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> than <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This contrasted to the activity pattern of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> active standard drugs <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, irinotecan and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Mechanistic studies indicated acriflavine to be a dual topoisomerase I and II inhibitor </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, the strategy used seems promising for identification of new diagnosis-specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs </plain></SENT>
</text></document>